Research commercialisation is a sequence of risk reductions. Scientific results must be translated into a defined use, reproducible evidence, appropriate ownership and a delivery model that a customer, operator or investor can support.
What matters most
A publication demonstrates knowledge but not necessarily a deployable solution.
Problem selection should involve users before engineering choices become fixed.
Ownership and contributor rights must be clear enough for external collaboration.
Demonstrations should test the assumptions most likely to block adoption.
A spin-out, licence, partnership or open model can each be appropriate depending on the asset.
The route should preserve scientific integrity while adding commercial evidence.
Questions to answer before acting
Use these questions to turn a broad topic into a defined decision, test or work package:
- Who has the problem and budget or authority to act?
- What result can be reproduced outside the originating laboratory?
- Who owns the foreground and background knowledge?
- Which adoption barrier should the next demonstration test?
A practical sequence
- Step 1. Define the user problem and operating environment.
- Step 2. Document the result, contributors and ownership.
- Step 3. Choose the next risk-reduction experiment.
- Step 4. Select a transfer or venture model.
- Step 5. Build the technical and commercial evidence package together.
Common traps
- Starting a company before defining the use
- Assuming a patent creates demand
- Demonstrating only in the original laboratory
Where this fits in the wider system
This topic belongs to the site’s Research commercialisation pillar. The strongest route normally connects several pillars: a research result may need a testbed, a consortium, an appropriate programme, standards work and a scale-up plan.
Use the planning tools to identify the next uncertainty, then verify the route through the official-source directory.